Mucopolysaccharidoses—What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview
Biomolecules · 2025
DOI: 10.3390/biom15101448 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Patryk Lipiński und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Sciences, Maria-Skłodowska-Curie Medical Academy, 00-136 Warsaw, Poland. Hauptthemen laut MEDLINE: Mucopolysaccharidoses. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The classification of mucopolysaccharidoses (MPSs) includes the classical types (I; II; III with subtypes A, B, C, and D; IV with subtypes A and B; VI; VII; IX; X), associated with impaired lysosomal degradation of mucopolysaccharides, also known as glycosaminoglycans (GAGs), as a result of deficiency in the specific enzymes responsible for GAG degradation (MPS IIIE has so far been identified only in animal models) and MPS-plus syndrome (MPSPS), which is characterized by an accumulation of undegraded GAGs, arising from impaired endosomal trafficking and inefficient delivery of these compounds to lysosomes (due to the VPS33A protein deficiency with normal GAG-degrading enzyme activities assessed in vitro). The aim of this comprehensive review is to provide physicians with a clinical, biochemical, and molecular overview of MPS manifestation. A brief summary of available and emerging therapies is also presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Sciences, Maria-Skłodowska-Curie Medical Academy, 00-136 Warsaw, Poland.
- Department of Pediatrics, Bielanski Hospital, 01-809 Warsaw, Poland.
- Anthropology Laboratory, Children's Memorial Health Institute, 04-730 Warsaw, Poland.
- Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-416 Gdansk, Poland.
- MEDGEN Medical Centre, 02-954 Warsaw, Poland.
- Department of Genetics, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.
ORCID-Profile: Patryk Lipiński, Agnieszka Różdżyńska-Świątkowska, Karolina Wiśniewska, Joanna Rusecka, Agnieszka Ługowska, Aleksandra Jezela-Stanek, Zuzanna Cyske, Lidia Gaffke, Karolina Pierzynowska, Grzegorz Węgrzyn
Zitieren
APA
Lipiński, P., Różdżyńska-Świątkowska, A., Wiśniewska, K., Rusecka, J., Ługowska, A., Żuber, Z., Jezela-Stanek, A., Cyske, Z., Gaffke, L., Pierzynowska, K., Węgrzyn, G., & Tylki-Szymańska, A. (2025). Mucopolysaccharidoses—What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview. Biomolecules. https://doi.org/10.3390/biom15101448
Vancouver
Lipiński P, Różdżyńska-Świątkowska A, Wiśniewska K, Rusecka J, Ługowska A, Żuber Z, et al. Mucopolysaccharidoses—What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview. Biomolecules. 2025. doi:10.3390/biom15101448
BibTeX
@article{Lipiski2025,
author = {Lipiński, Patryk and Różdżyńska-Świątkowska, Agnieszka and Wiśniewska, Karolina and Rusecka, Joanna and Ługowska, Agnieszka and Żuber, Zbigniew and Jezela-Stanek, Aleksandra and Cyske, Zuzanna and Gaffke, Lidia and Pierzynowska, Karolina and Węgrzyn, Grzegorz and Tylki-Szymańska, Anna},
title = {Mucopolysaccharidoses—What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15101448}
}
EUVIMED